MAPT and early-onset autosomal dominant Alzheimer disease: These CSF biomarkers, namely total-tau protein (τT), phosphorylated-tau protein (τP) and β-amyloid peptide with 42 amino acids (Aβ42) have already been successfully incorporated in Alzheimer’s Disease (AD) diagnostic criteria used for research purposes [13,14].